HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Kato Selected Research

Inflammation (Inflammations)

12/2023IL-13 and IL-13 induced periostin are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis.
1/2023Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps.
1/2023Genetics and epigenetics of chronic rhinosinusitis.
1/2022Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.
1/2022Mechanisms and pathogenesis of chronic rhinosinusitis.
1/2021Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps.
1/2021Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease.
1/2021Group 2 innate lymphoid cells in nasal polyposis.
1/2020Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis.
1/2020Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Kato Research Topics

Disease

58Neoplasms (Cancer)
03/2023 - 01/2002
42Nasal Polyps (Nasal Polyp)
12/2023 - 06/2008
41Rhinosinusitis
12/2023 - 06/2008
29Inflammation (Inflammations)
12/2023 - 04/2002
23Infections
01/2023 - 12/2002
18Pancreatic Neoplasms (Pancreatic Cancer)
10/2019 - 10/2004
14Neoplasm Metastasis (Metastasis)
04/2022 - 05/2003
14Asthma (Bronchial Asthma)
01/2022 - 10/2004
11Virus Diseases (Viral Diseases)
05/2022 - 06/2002
10Ischemia
11/2016 - 04/2002
9Gaucher Disease (Gaucher's Disease)
08/2022 - 12/2006
9Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2019 - 01/2002
9Cholangiocarcinoma
11/2017 - 01/2004
9Hepatocellular Carcinoma (Hepatoma)
09/2016 - 05/2003
7Polyps
11/2022 - 01/2010
7Pathologic Constriction (Stenosis)
02/2017 - 07/2008
7Klatskin Tumor
12/2014 - 04/2005
7Obstructive Jaundice (Cholestatic Jaundice)
06/2014 - 04/2005
6Carcinoma (Carcinomatosis)
01/2017 - 10/2004
6Reperfusion Injury
03/2011 - 04/2002
5Thrombosis (Thrombus)
07/2017 - 11/2007
5Head and Neck Neoplasms (Head and Neck Cancer)
05/2017 - 11/2014
5Edema (Dropsy)
11/2014 - 03/2004
5Hyperglycemia
02/2014 - 09/2008
4Hypersensitivity (Allergy)
01/2022 - 05/2009
4Hemorrhage
01/2018 - 01/2005
4Eosinophilia
11/2017 - 04/2015
4Ascites
02/2017 - 11/2006
3Lysosomal Storage Diseases (Lysosomal Storage Disease)
02/2023 - 03/2005
3Pneumonia (Pneumonitis)
02/2021 - 05/2013
3Mycoplasma Pneumonia
02/2021 - 08/2013
3Hyperbilirubinemia
02/2019 - 06/2014
3Sigmoid Neoplasms
02/2019 - 11/2007
3Thrombocytopenia (Thrombopenia)
02/2019 - 04/2003
3Lymphatic Metastasis
11/2017 - 11/2015
3Type 2 Diabetes Mellitus (MODY)
01/2017 - 01/2011
3Heart Failure
09/2016 - 02/2015
3Adenocarcinoma
04/2016 - 06/2009
3Cholangitis
11/2015 - 05/2010
3Fever (Fevers)
11/2015 - 05/2013
3Hypertrophy
06/2014 - 08/2004
3Liver Failure
06/2014 - 10/2004
3Hyperalgesia
07/2009 - 03/2009

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2002
20CytokinesIBA
01/2023 - 03/2004
16Messenger RNA (mRNA)IBA
01/2017 - 05/2003
10GemcitabineFDA Link
11/2017 - 08/2007
9GlucosidasesIBA
02/2023 - 12/2012
8Interleukin-13IBA
12/2023 - 02/2003
8Biomarkers (Surrogate Marker)IBA
12/2023 - 12/2015
8Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 05/2009
8EnzymesIBA
08/2021 - 01/2016
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 02/2013
7Interleukin-6 (Interleukin 6)IBA
01/2018 - 06/2004
6Thymic Stromal LymphopoietinIBA
01/2023 - 07/2007
6AntibodiesIBA
07/2017 - 04/2003
5Interleukin-5 (Interleukin 5)IBA
11/2022 - 04/2015
5Antiviral Agents (Antivirals)IBA
01/2021 - 09/2005
5Cisplatin (Platino)FDA LinkGeneric
11/2017 - 05/2005
5AntigensIBA
04/2013 - 06/2002
4Glycoside Hydrolases (Endoglycosidases)IBA
05/2022 - 03/2005
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2004
4Immunoglobulin G (IgG)IBA
01/2022 - 12/2011
4MacrolidesIBA
02/2021 - 05/2013
4Immunoglobulin E (IgE)IBA
01/2021 - 11/2009
4Glucosylceramidase (Glucocerebrosidase)IBA
04/2020 - 12/2006
4Glucose (Dextrose)FDA LinkGeneric
12/2019 - 06/2010
4MucinsIBA
11/2019 - 05/2010
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2019 - 03/2009
4ChemokinesIBA
07/2011 - 11/2009
3pyrrolidineIBA
02/2023 - 01/2016
3Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2022 - 09/2005
3FibrinIBA
11/2022 - 01/2013
3Immunoglobulins (Immunoglobulin)IBA
11/2022 - 06/2008
3VaccinesIBA
07/2022 - 03/2015
3Indicators and Reagents (Reagents)IBA
04/2022 - 11/2008
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 10/2004
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 02/2010
3Peroxidase (Myeloperoxidase)IBA
11/2019 - 03/2004
3Tumor Biomarkers (Tumor Markers)IBA
02/2019 - 11/2014
3LigandsIBA
01/2018 - 01/2012
3Small Interfering RNA (siRNA)IBA
11/2017 - 11/2008
3Peptide Hydrolases (Proteases)FDA Link
04/2016 - 11/2009
3Interferon Type IIBA
08/2015 - 09/2008
3B-Cell Activating FactorIBA
10/2012 - 06/2008
3Interleukin-1 (Interleukin 1)IBA
07/2012 - 11/2002
3Interleukin-10 (Interleukin 10)IBA
03/2009 - 02/2003
3NF-kappa B (NF-kB)IBA
10/2004 - 07/2002

Therapy/Procedure

23Hepatectomy
04/2022 - 01/2004
20Therapeutics
01/2023 - 10/2004
20Drug Therapy (Chemotherapy)
10/2019 - 11/2004
14Pancreaticoduodenectomy
05/2017 - 03/2006
12Pancreatectomy
01/2023 - 10/2004
9Stents
11/2022 - 11/2006
7Operative Surgical Procedures
09/2017 - 01/2002
4Neoadjuvant Therapy
06/2019 - 10/2012
3Splenectomy
01/2018 - 10/2003
3Segmental Mastectomy (Lumpectomy)
11/2015 - 11/2007
3Liver Transplantation
01/2014 - 07/2005
3Adjuvant Chemotherapy
12/2012 - 11/2008